Epameinondas V. Tsianos

Epameinondas V. Tsianos

Auto-generated profile, based on publicly available information

Epameinondas V. Tsianos

1st Department of Internal Medicine & Hepato-Gastroenterology Unit, University Hospital of Ioannina, Greece

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ETEpameinondas V Tsianos
Epameinondas V Tsianos
Considering epidemiological, genetic and immunological data, we can conclude that the inflammatory bowel diseases are heterogeneous disorders of multifactorial etiology in which hereditability and environment interact to produce the disease. It is probable that patients have a genetic predisposition for the development of the disease coupled with disturbances in immunoregulation. Several genes have been so far related to the diagnosis of Crohn's disease. Those genes are related to innate pattern recognition receptors, to epithelial barrier homeostasis and maintenance of epithelial barrier integrity, to autophagy and to lymphocyte differentiation. So far, the most strong and replicated associations with Crohn's disease have been done with NOD2, IL23R and ATG16L1 genes. Many genes have so far been implicated in prognosis of Crohn's disease and many attempts have been made to classify genetic profiles in Crohn's disease. CARD15 seems not only a susceptibility gene, but also a disease-modifier gene for Crohn's disease. Enriching our understanding on Crohn's disease genetics is important but when combining genetic data with functional data the outcome could be of major importance to clinicians.

26 September 2011 in Liver International
Verified
Journal Article
Closed access
PDF file
GKGeorgios N. Kalambokis
Georgios N. Kalambokis
AMAthanasia Mouzaki
Athanasia Mouzaki
MRMaria Rodi
Maria Rodi
ETEpameinondas V. Tsianos
Epameinondas V. Tsianos

24 December 2010 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
PDF file
DCDimitrios K. Christodoulou
Dimitrios K. Christodoulou
HMHaralampos J. Milionis
Haralampos J. Milionis
PPPanagiota Pappa
Panagiota Pappa
KKKonstantinos H. Katsanos
Konstantinos H. Katsanos
DSDimitrios Sigounas
Dimitrios Sigounas
ETEpameinondas V. Tsianos
Epameinondas V. Tsianos

1 January 2009 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ETEpameinondas V Tsianos
Epameinondas V Tsianos
KKKonstantinos Katsanos
Konstantinos Katsanos
Do we really understand what the immunological disturbances in inflammatory bowel disease mean?

16 October 2008 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
CZC. D. Zois
C. D. Zois
GBG. H. Baltayiannis
G. H. Baltayiannis
PKPeter Karayiannis
Peter Karayiannis
ETE. V. Tsianos
E. V. Tsianos
Summary: Background  Hepatic fibrosis occurs in response to chronic liver injury, regardless of the cause. An impressive amount of knowledge concerning the pathogenesis and treatment of liver fibrosis has emerged over the past few years. The hallmark of this event is the activation of the hepatic stellate cell. The latter event causes accumulation of extracellular matrix and formation of scar, leading to deterioration in hepatic function.Aim  To assess chronic liver injury, many invasive and non‐invasive methods have been suggested.Methods  Although transient elastography, image analysis of fractal geometry and fibrotest with actitest have been used in clinical practice, liver biopsy remains the recommended choice, especially when histological staging of fibrosis or response to treatment is needed.Conclusions  The recent advances in anti‐viral therapy have resulted in many reports on fibrosis and even on cirrhosis regression, especially early and in young people. A number of new agents have been suggested for the treatment of fibrosis, with promising results in animals; however, their efficacy in humans remains to be elucidated. The investigation of heterogeneity and plasticity of hepatic stellate cells is a topic of scientific interest and may result in improvements in patient management.

1 October 2013 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
APAthanasios Papathanasopoulos
Athanasios Papathanasopoulos
LOLukas Van Oudenhove
Lukas Van Oudenhove
KKKonstantinos Katsanos
Konstantinos Katsanos
DCDimitrios Christodoulou
Dimitrios Christodoulou
JTJan Tack
Jan Tack
ETEpameinondas V. Tsianos
Epameinondas V. Tsianos
Background. Fecal incontinence (FI) and urgency are prevalent symptoms in patients with inflammatory bowel diseases (IBD). It is unclear which factors determine